Gilead begins testing inhalable form of remdesivir for COVID-19 The drug is currently used intravenously and an inhaled formulation would be given through a nebuliser Gilead Sciences has…
Gilead Sciences launches 2019 Gilead Asia Pacific Rainbow Grants programme The programme seeks to improve quality of life of people living with HIV by focussing on access and quality of life,…
